NCT03708120 is a NA clinical trial of Citrepel (Insect Repellent) EPA Reg. No. 84878-2 in Tick Bites, sponsored by ARCTEC.

Who is sponsoring NCT03708120?

NCT03708120 is sponsored by ARCTEC.

What drugs are being tested in NCT03708120?

Interventions in NCT03708120: Citrepel (Insect Repellent) EPA Reg. No. 84878-2.

What condition does NCT03708120 study?

NCT03708120 studies Tick Bites.

Is NCT03708120 still recruiting?

NCT03708120 is currently completed. Last updated 13 November 2019.

Last reviewed 2019-11-13 · How we verify

NCT03708120

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Determining the Complete Protection Time of an Insect Repellent With 30% Citriodiol® Against Three Species of Ticks.

Completed NA Last updated 13 November 2019

What this trial tests

NA trial testing Citrepel (Insect Repellent) EPA Reg. No. 84878-2 in Tick Bites in 70 participants. Completed in 18 October 2019.

Timeline

15 November 2018

Primary endpoint
18 October 2019

18 October 2019

Quick facts

Lead sponsor	ARCTEC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	70
Start date	15 November 2018
Primary completion	18 October 2019
Estimated completion	18 October 2019
Sites	1 location across United Kingdom

Drugs / interventions tested

Citrepel (Insect Repellent) EPA Reg. No. 84878-2

Conditions studied

Tick Bites — all drugs for Tick Bites →

Sponsor

ARCTEC

Who can join

Adults 18 to 65, any sex, with Tick Bites. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the length of time an insect repellent product can protect against three species of ticks. Participants will have one arm treated with the repellent, and throughout the next 10 hours, ticks will be given the opportunity to crawl up the treated arm. The test will stop after 10 hours or when the repellent stops working whichever occurs sooner.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tick Bites

Currently open trials in the same condition.

NCT07479537 — Acquired Tick Resistance in Naturally Exposed Participants · NA · active not recruiting

Other ARCTEC trials

Trials by the same sponsor.

NCT04948190 — Canine COVID-19 Detection Phase 2 and 3 · unknown
NCT04509713 — Canine COVID-19 Detection · unknown
NCT04028180 — Comparison Trial Between Two Repellent Products and a Positive Control Against Culicoides Nubeculosus Midges · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03708120 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ARCTEC
Last refreshed: 13 November 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03708120.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing